Alterity Therapeutics Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.

Dilution of Shares: Shareholders have been substantially diluted in the past year, with total shares outstanding growing by 118.1%.

Top 25 shareholders own 91.29% of the company

Ownership	Name	Shares	Current Value	Change %	Portfolio %
75.5%	BNY Asset Management	4,015,070,096	€7.5m	107%	no data
3.45%	Regal Partners Limited	183,370,294	€341.4k	0%	0.02%
2.35%	Merrill Lynch & Co. Inc., Banking Investments	125,280,000	€233.2k	0%	no data
2.33%	JPMorgan Chase & Co, Brokerage and Securities Investments	123,856,611	€230.6k	-66.4%	no data
2.15%	Life Biosciences, Inc.	114,560,553	€213.3k	0%	no data
0.72%	Jagen Pty Ltd	38,556,497	€71.8k	0%	0.92%
0.55%	Morgan Stanley, Investment Banking and Brokerage Investments	29,027,400	€54.0k	-6.94%	no data
0.4%	Anurag Pandey	21,042,904	€39.2k	0%	no data
0.34%	Geoffrey Kempler	18,011,000	€33.5k	0%	no data
0.34%	Elif Gunes	18,000,000	€33.5k	0%	no data
0.33%	Andrew Seton	17,627,333	€32.8k	0%	no data
0.29%	Rentuk Shore Pty Ltd	15,641,719	€29.1k	0%	no data
0.29%	Lan Au Buu	15,489,010	€28.8k	0%	no data
0.26%	Susquehanna International Group, LLP, Asset Management Arm	13,986,600	€26.0k	0%	no data
0.23%	Lu Jia	12,418,724	€23.1k	0%	no data
0.23%	Kate Schroeter	12,111,001	€22.5k	0%	no data
0.2%	David Southon	10,704,781	€19.9k	0%	no data
0.2%	Fagan Harris Pty Ltd	10,500,000	€19.5k	0%	no data
0.19%	Jason Khoo	10,000,000	€18.6k	0%	no data
0.18%	Huy Nguyen	9,759,218	€18.2k	0%	no data
0.18%	Rebecca Nguyen	9,759,218	€18.2k	0%	no data
0.18%	Benjamin Woolvett	9,628,571	€17.9k	0%	no data
0.15%	Minh Huy Lam	8,000,000	€14.9k	0%	no data
0.14%	Brian Meltzer	7,469,523	€13.9k	0%	no data
0.14%	Peter Marks	7,185,986	€13.4k	0%	no data